University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

B

Status Drug name NICE TAs Comments
Status: Green Betamethasone 0.1% with neomycin 0.5% eardrops (Betnesol N)
Status: Amber Betamethasone 0.1%, neomycin 0.5% eye drops

Short term use only

Status: Green Betamethasone ear drops
Status: Green Betamethasone eye/ear/nose drops
Status: Green Betamethasone valerate 0.025% cream

Betnovate RD. Moderate potency.

Status: Green Betamethasone valerate 0.025% ointment

Betnovate RD. Moderate potency.

Status: Green Betamethasone valerate 0.1% cream

Betnovate®. Potent potency.

Status: Green Betamethasone valerate 0.1% ointment

Betnovate®. Potent potency.

Status: Green Betamethasone valerate 0.1% scalp application

Betnovate®. Potent potency.

Status: Amber Betaxolol eye drops

Specialist ophthalmologist recommendation
0.25% ophthalmic suspension
0.5% eye drops
0.5% unit dose eye drops

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top